Return to Activities After Simultaneous Bilateral Endoscopic Carpal Tunnel Release.

Journal Article (Journal Article)

BACKGROUND: Approximately 56% of patients diagnosed with carpal tunnel syndrome present with bilateral symptoms; however, few studies have investigated bilateral simultaneous endoscopic carpal tunnel release (ECTR) and postoperative effect on return to activity. The purpose of this study was to evaluate the length of recovery in patients who received bilateral simultaneous ECTR, including pain medication requirements, return to activities of daily living, return to work, and return to recreational activities. METHODS: A retrospective analysis was performed on patients who underwent bilateral ECTR by a single hand fellowship-trained surgeon from 2013 to 2019. Demographic, operative, and clinical outcomes were collected via chart review and a telephone interview. Student t tests and χ2 tests were conducted for analysis. RESULTS: Eighty patients were included in the study; 40 were successfully contacted for telephone interview follow-up. Patients reported an average of 2 days of use of postoperative narcotic pain medication and an average of 5, 7, and 19 days of return to activities of daily living, work, and recreational activities, respectively. Female patients reported more days of narcotic pain medications (1 day vs 3 days, P = .0483) and an average of longer return to work than men (9 days vs 5 days, P = .0477). Manual laborers reported longer return to work (9 days vs 5 days, P = .0500). Older patients (aged >65 years) reported longer return to recreational activities (39 days vs 11 days, P = .0189). CONCLUSIONS: Simultaneous bilateral ECTR is a successful procedure with shorter recovery times than reported previously. Female patients, manual laborers, and older patients experience a longer recovery and should be counseled appropriately.

Full Text

Duke Authors

Cited Authors

  • Hein, RE; Hollins, AW; Fletcher, AN; Ruch, DS; Richard, MJ; Mithani, SK

Published Date

  • July 2022

Published In

Volume / Issue

  • 17 / 4

Start / End Page

  • 646 - 651

PubMed ID

  • 32940056

Pubmed Central ID

  • PMC9274870

Electronic International Standard Serial Number (EISSN)

  • 1558-9455

Digital Object Identifier (DOI)

  • 10.1177/1558944720940061


  • eng

Conference Location

  • United States